Huma at HLTH 2022
We are part of a global movement to bring digital technology to healthcare and research. Learn more about how Huma's technology has been used to drive better care outcomes for patients and also powered hybrid and decentralised clinical trials.
Huma partnership provides a new lease of life for Welsh patients living with heart failure
The Huma app has been used to remotely monitor heart failure patients at home, building better relationships between patients and clinicians during the COVID-19 pandemic. Hear more from Huma, the clinicians, and the patients involved in this important project below.
Huma has been chosen as finalists in the UCSF Awards, to be presented at HLTH 2022. Read more about our projects below.
DeTAP Study: Huma's technology drives patient recruitment and adherence
Find out more about Huma’s partnership with Bayer and Stanford University in the DeTAP study, where Huma’s platform was used to power a decentralised clinical trial, resulting in better recruitment of participants and increased adherence to heart medication.
Huma's awards in 2022
Talk to us
Download a peer-reviewed study of our DCT platform carried out with Stanford and Bayer
Enrolled participants used Huma's app to provide data from blood pressure devices and ECG sensors, collect symptoms, take clinical surveys, and have televisits.
Talk to us
London
Millbank Tower
21-24 Millbank
London SW1P 4QP
UK
New York
14 Penn Plaza
225 West 34th Street
Floor 9
New York NY 10122
USA
